LifeScience
JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth ra...
September 22, 2022 | News
ClavystBio, a company established by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek, today announced its launch to accelerate the commercia...
September 15, 2022 | News
BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market Application p...
September 12, 2022 | News
Increases manufacturing capacity for the Mobius® single-use portfolio Creates more than 800 jobs by the end of 2028 Investment further strengt...
September 12, 2022 | News
Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...
September 02, 2022 | News
This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...
September 01, 2022 | News
Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...
August 29, 2022 | News
Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...
August 25, 2022 | News
Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...
August 24, 2022 | News
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...
August 23, 2022 | News
Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...
August 18, 2022 | News
Highlights: Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core(1) basis. GAAP net income of $329 million ...
August 17, 2022 | News
Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, announces a new addition to its range of pro...
August 10, 2022 | News
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...
August 09, 2022 | News
Most Read
Bio Jobs
News
Editor Picks